Publications by authors named "Matteo Carrabba"

Claim this Profile
B
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.
Edoardo Campodonico, Piera Angelillo, Matteo Doglio, Alessia Ugolini, Maria Teresa Lupo Stanghellini, Matteo G Carrabba

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Marco Cerrano, Matteo G Carrabba

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas.
Federico Stella, Annalisa Chiappella, Beatrice Casadei, Stefania Bramanti, Silva Ljevar, Matteo G Carrabba

Blood Cancer Discov· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report.
Elisa Diral, Gloria Catalano, Maria Vittoria Cicinelli, Andrea Distefano, Sara Mastaglio, Matteo G Carrabba

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Matteo G Carrabba

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience.
Elisabetta Xue, Gianluca Scorpio, Annalisa Ruggeri, Daniela Clerici, Francesca Farina, Matteo G Carrabba

Curr Res Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Daniela Clerici, Laura Galli, Raffaella Greco, Anna P Lugli, Federico Erbella, Matteo G Carrabba

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Matteo Maria Naldini, Gabriele Casirati, Matteo Barcella, Paola Maria Vittoria Rancoita, Andrea Cosentino, Matteo Giovanni Carrabba

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia.
Fabio Giglio, Edoardo Campodonico, Francesca Lorentino, Maddalena Noviello, Elisabetta Xue, Matteo Giovanni Carrabba

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minnesota acute graft--host disease risk score predicts survival at onset of graft--host disease after post-transplant cyclophosphamide prophylaxis.
Federica Ardizzoia, Francesca Lorentino, Alessandro Bruno, Sarah Marktel, Fabio Giglio, Matteo G Carrabba

Haematologica· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
Massimo Bernardi, Felicetto Ferrara, Matteo Giovanni Carrabba, Sara Mastaglio, Francesca Lorentino

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse.
Valentina Gambacorta, Stefano Beretta, Martina Ciccimarra, Laura Zito, Kety Giannetti, Matteo Giovanni Carrabba

Cancer Discov· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.
Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Matteo G Carrabba

J Clin Invest· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.
Carmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, Luca Vago, Matteo Giovanni Carrabba

Ther Adv Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Francesca Lorentino, Elisabetta Xue, Sara Mastaglio, Fabio Giglio, Daniela Clerici, Matteo G Carrabba

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience.
Simona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri, Magda Marcatti, Maria Teresa Lupo Stanghellini, Matteo Giovanni Carrabba

Bone Marrow Transplant· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a maturity model for facilitating the introduction of CAR T-cell therapy-Results of the START CAR-T project.
Stefania Bramanti, Matteo G Carrabba, Alice Di Rocco, Elena Fabris, Luca Gastaldi

Glob Reg Health Technol Assess· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Raffaella Greco, Francesca Lorentino, Serena Albanese, Maria Teresa Lupo Stanghellini, Fabio Giglio, Matteo G Carrabba

Transplant Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.
Fabio Serpenti, Francesca Lorentino, Sarah Marktel, Raffaella Milani, Carlo Messina, Matteo G Carrabba

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients.
Raffaella Greco, Rosamaria Nitti, Nicasio Mancini, Renée Pasciuta, Francesca Lorentino, Matteo G Carrabba

Blood· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Geoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, Peter H Sayre, Matthew J Wieduwilt, Matteo Giovanni Carrabba

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Following-up allogeneic transplantation recipients during the COVID-19 pandemic.
Maria Teresa Lupo-Stanghellini, Carlo Messina, Sarah Marktel, Matteo G Carrabba, Jacopo Peccatori

Lancet Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanosphere's Verigene Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance.
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, Laura Infurnari, Renée Pasciuta, Matteo Giovanni Carrabba

Clin Hematol Int· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.
Cristina Toffalori, Laura Zito, Valentina Gambacorta, Michela Riba, Giacomo Oliveira, Matteo G Carrabba

Nat Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
Alessandra Forcina, Francesca Lorentino, Vincenzo Marasco, Chiara Oltolini, Magda Marcatti, Matteo Carrabba

Biol Blood Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis